THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2018

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2018

WEBINARS

Register Now and
On Demand

Home » Category

CAP TODAY Recommends

CMS national coverage decision on next-generation sequencing

A new white paper titled “The CMS National Coverage Decision on NGS” from Diaceutics provides coverage of ongoing developments since the NGS national coverage decision was made. Read the white paper (requires free registration).

NovoPath-sponsored session at 23rd annual Executive War College conference

NovoPath is sponsoring an educational session on how laboratories can use Lean and Six Sigma principles at the 23rd annual Executive War College Conference on Laboratory and Pathology Management, May 1–2 in New Orleans.

Cancer Biomarkers Conference III

Houston Methodist Department of Pathology and Genomic Medicine is presenting its Cancer Biomarkers Conference III, Sept. 15–16, at the Houston Methodist Research Institute. More than 20 speakers will cover topics such as updates on PD-L1 testing for lung cancer, urologic cancers, and melanoma, the current approach to using cytology specimens for biomarker testing, the oncologist’s approach to TKI therapy, and many more.

Tissue Oxygenation Workshop 2018

The National Heart, Lung, and Blood Institute, National Institutes of Health, and the Department of Health and Human Services Office of the Assistant Secretary for Health are sponsoring a tissue oxigination workshop: “Towards Minimally-invasive or Non-invasive Approaches to Assess Tissue Oxygenation Pre- and Post-Transfusion Workshop 2018.” The workshop will be held April 23–24 at the Neuroscience Center in Rockville, Md.

Connecting Labs to Greater Medical Value:
How three hospitals are discovering new possibilities
with connected core labs

August 2017—The advent of the connected core lab is here, and labs of all sizes can take advantage of the unprecedented possibilities it affords. When they do, they’ll find that they have the power and the flexibility to meet the demands of today and the needs of tomorrow while delivering greater medical value across their healthcare systems.

The future of the lab in health care

In a collaborative effort to discuss the future of the laboratory in health care, Bob McGonnagle, publisher of CAP TODAY, gathered with Orchard Software’s Curt Johnson, chief operating officer, and Matt Modleski, chief operating officer, American Health Network. This roundtable, recorded in May 2017, was edited into a series of seven short videos.

Seeing Sepsis with New Eyes
How a new PCT assay is bringing critical insights to light.

How fast can we find better ways to win the fight against sepsis? For hospitals, healthcare professionals and patients across the country, that answer can’t come soon enough. Consider this: In the five or so minutes it will take an average reader to finish this article, more than two people will die from sepsis in the United States. That’s one person every two minutes.

2017 Pulmonary Pathology Society 10th Biennial Meeting

Interest in lung disease has exploded in recent years due to a staggering number of developments in diagnosis and treatment. Where there was once no hope, there is now optimism and excitement. The Pulmonary Pathology Society is the world’s largest organization of experts in lung pathology. Our 2017 Biennial Meeting will take place at the University of Chicago’s Gleacher Center on Chicago’s Magnificent Mile on June 13 through 16.

Improve triaging in the ED
A new assay delivers a higher standard of cardiac care

Improve triaging in the ED: A new assay delivers a higher standard of cardiac care. “Is it a heart attack, or something less serious?” Every day, thousands of symptomatic patients ask emergency department (ED) physicians that very question. Over the years, as diagnostic tools for acute myocardial infarction (AMI), commonly known as a heart attack, have advanced, physicians can provide increasingly accurate answers to that question. Unfortunately, diagnostic gaps still exist that can result in poor patient outcomes.

Digital pathology association stands behind FDA’s approval of marketing whole slide imaging system

April 13, 2017—The Digital Pathology community is in full support of the FDA’s landmark announcement that Philips Whole Slide Imaging (WSI) system, IntelliSite, can be marketed for primary diagnosis. This technology facilitates review of digital surgical pathology slides with remote sign out capabilities, and poses a significant benefit to both pathologists and patients alike.

X